The Custom Recombinant Antibody Conversion Service Market Industry is experiencing a significant evolution as the expanding therapeutic antibody pipeline, particularly in oncology, autoimmune diseases, and infectious diseases, creates sustained demand for conversion services that can support the development of novel biologic candidates. This industry transformation is being propelled...